Skip Nav Destination
Issues
15 October 2019
-
Cover Image
Cover Image
Chemotherapeutic elimination (green) of the tumor is a complex challenge. Mathematical modeling of tumor-immune interactions reveals that optimal therapy, which may initially seem black and white, requires delicate navigation through a complex multidimensional landscape personalized to each patient. Cytotoxic efficacy (purple) must be balanced with supporting patient antitumor immune responses stimulated by lymphodepletion (blue). Optimal therapy treads an intermediate path (gold) that maintains dosing within a maximally effective window. The authors acknowledge the help of Dr. Chandler D. Gatenbee who provided coding expertise on the coloring for the image. For details, see article by Park and colleagues on page 5302. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Issue Sections
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Insights
Reviews
Cancer Research Highlights
Priority Report
miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells
Junko Mukohyama; Taichi Isobe; Qingjiang Hu; Takanori Hayashi; Takashi Watanabe; Masao Maeda; Hisano Yanagi; Xin Qian; Kimihiro Yamashita; Hironobu Minami; Koshi Mimori; Debashis Sahoo; Yoshihiro Kakeji; Akira Suzuki; Piero Dalerba; Yohei Shimono
Genome and Epigenome
Metabolism and Chemical Biology
Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia
Mohsen Hosseini; Hamid Reza Rezvani; Nesrine Aroua; Claudie Bosc; Thomas Farge; Estelle Saland; Véronique Guyonnet-Dupérat; Sonia Zaghdoudi; Latifa Jarrou; Clément Larrue; Marie Sabatier; Pierre Luc Mouchel; Mathilde Gotanègre; Marc Piechaczyk; Guillaume Bossis; Christian Récher; Jean-Emmanuel Sarry
Molecular Cell Biology
CDK4 Regulates Lysosomal Function and mTORC1 Activation to Promote Cancer Cell Survival
Laia Martínez-Carreres; Julien Puyal; Lucía C. Leal-Esteban; Meritxell Orpinell; Judit Castillo-Armengol; Albert Giralt; Oleksandr Dergai; Catherine Moret; Valentin Barquissau; Anita Nasrallah; Angélique Pabois; Lianjun Zhang; Pedro Romero; Isabel C. Lopez-Mejia; Lluis Fajas
Tumor Biology and Immunology
Prolactin Promotes Fibrosis and Pancreatic Cancer Progression
Manuj Tandon; Gina M. Coudriet; Angela Criscimanna; Mairobys Socorro; Mouhanned Eliliwi; Aatur D. Singhi; Zobeida Cruz-Monserrate; Peter Bailey; Michael T. Lotze; Herbert Zeh; Jing Hu; Vincent Goffin; George K. Gittes; Andrew V. Biankin; Farzad Esni
Translational Science
Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis
Yasuyuki Mizutani; Hiroki Kobayashi; Tadashi Iida; Naoya Asai; Atsushi Masamune; Akitoshi Hara; Nobutoshi Esaki; Kaori Ushida; Shinji Mii; Yukihiro Shiraki; Kenju Ando; Liang Weng; Seiichiro Ishihara; Suzanne M. Ponik; Matthew W. Conklin; Hisashi Haga; Arata Nagasaka; Takaki Miyata; Makoto Matsuyama; Tomoe Kobayashi; Tsutomu Fujii; Suguru Yamada; Junpei Yamaguchi; Tongtong Wang; Susan L. Woods; Daniel Worthley; Teppei Shimamura; Mitsuhiro Fujishiro; Yoshiki Hirooka; Atsushi Enomoto; Masahide Takahashi
In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis
Orli Yogev; Gilberto S. Almeida; Karen T. Barker; Sally L. George; Colin Kwok; James Campbell; Magdalena Zarowiecki; Dimitrios Kleftogiannis; Laura M. Smith; Albert Hallsworth; Philip Berry; Till Möcklinghoff; Hannah T. Webber; Laura S. Danielson; Bliss Buttery; Elizabeth A. Calton; Barbara M. da Costa; Evon Poon; Yann Jamin; Stefano Lise; Gareth J. Veal; Neil Sebire; Simon P. Robinson; John Anderson; Louis Chesler
Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity
Prabhani U. Atukorale; Shruti P. Raghunathan; Vanitha Raguveer; Taylor J. Moon; Carolyn Zheng; Peter A. Bielecki; Michelle L. Wiese; Amy L. Goldberg; Gil Covarrubias; Christopher J. Hoimes; Efstathios Karathanasis
Convergence and Technologies
Population and Prevention Science
High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium
Lauren C. Peres; Adrianne R. Mallen; Mary K. Townsend; Elizabeth M. Poole; Britton Trabert; Naomi E. Allen; Alan A. Arslan; Laure Dossus; Renée T. Fortner; Inger T. Gram; Patricia Hartge; Annika Idahl; Rudolf Kaaks; Marina Kvaskoff; Anthony M. Magliocco; Melissa A. Merritt; J. Ramón Quirós; Anne Tjonneland; Antonia Trichopoulou; Rosario Tumino; Carla H. van Gils; Kala Visvanathan; Nicolas Wentzensen; Anne Zeleniuch-Jacquotte; Shelley S. Tworoger
Resource Report
Correction
Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors
Martin Indarte; Roisin Puentes; Marco Maruggi; Nathan T. Ihle; Geoffrey Grandjean; Michael Scott; Zamal Ahmed; Emmanuelle J. Meuillet; Shuxing Zhang; Robert Lemos, Jr; Lei Du-Cuny; Fabiana I.A.L. Layng; Ricardo G. Correa; Laurie A. Bankston; Robert C. Liddington; Lynn Kirkpatrick; Garth Powis
Editor’s Note
Retraction
Advertisement